Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?

Published:2017-05-04 Issue:5 Volume:10 Page:479-492
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Mussetti Alberto¹,Greco Raffaella²,Peccatori Jacopo²,Corradini Paolo¹³

Affiliation:

1. Division of Hematology and Bone Marrow Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2. Hematology and Bone Marrow Transplantation (BMT) Unit, San Raffaele Scientific Institute, Milan, Italy

3. Dipartimento di Oncologia ed Emato-oncologia, Universita’ degli Studi di Milano, Milan, Italy

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2017.1318054

Reference84 articles.

1. Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

2. Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

3. Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

4. Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

5. Marrow Transplantation from Related Donors Other Than HLA-Identical Siblings

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings;Bone Marrow Transplantation;2024-08-15

2. Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD;Blood Advances;2023-07-27

3. Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation;Haematologica;2022-10-06

4. A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice;Blood;2022-03-17

5. Unrelated donor α/β T-cell and B-cell-depleted HSCT for the treatment of pediatric acute leukemia;Blood Advances;2021-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3